Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

76.59
-0.0100-0.01%
Pre-market: 76.850.2600+0.34%08:35 EDT
Volume:2.06M
Turnover:157.22M
Market Cap:15.00B
PE:-21.46
High:77.24
Open:76.20
Low:75.02
Close:76.60
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:1.42
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.96
PE(LYR):-20.24

Loading ...

BridgeBio publishes acoramidis-versus-tafamidis ATTR-CM analysis presentation

Reuters
·
May 11

BRIEF-Acoramidis Continues To Demonstrate Disease-Modifying Effects In ATTR-CM

Reuters
·
May 11

BridgeBio says acoramidis cuts outpatient worsening heart failure risk 41% in Phase 3 trial

Reuters
·
May 11

Acoramidis Continues to Demonstrate Disease-Modifying Effects in Attr-Cm, Reducing Sttr Variability and Outpatient Worsening Heart Failure

THOMSON REUTERS
·
May 11

BridgeBio Pharma Inc - Acoramidis Reduces Cardiovascular Hospitalizations by 34% Versus Tafamidis

THOMSON REUTERS
·
May 11

BridgeBio Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 11

BridgeBio Pharma, Inc. : H.c. Wainwright Raises Target Price to $110 From $100

THOMSON REUTERS
·
May 11

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), BridgeBio Pharma (BBIO) and Globus Medical (GMED)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

A Look At BridgeBio Pharma (BBIO) Valuation After Strong Long Term Gains And Recent Share Price Weakness

Simply Wall St.
·
May 11

BRIEF-Bridgebio Pharma reports inducement grants under Nasdaq listing rule 5635(C)(4)

Reuters
·
May 09

BridgeBio grants 115,007 restricted stock units to 52 new employees

Reuters
·
May 09

BridgeBio price target raised to $130 from $125 at Evercore ISI

TIPRANKS
·
May 09

BridgeBio price target lowered to $94 from $98 at Morgan Stanley

TIPRANKS
·
May 08

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 08

BridgeBio Pharma launches at-the-market equity program for up to $500 million

Reuters
·
May 08

RBC Capital Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
May 08

BridgeBio price target raised to $114 from $100 at Bernstein

TIPRANKS
·
May 08

BridgeBio files automatic mixed securities shelf

TIPRANKS
·
May 08

BRIEF-BridgeBio Pharma Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
May 08